Clarivate


Clarivate is a Philadelphia and London-based company formed in 2016, following the acquisition of Thomson Reuters' Intellectual Property and Science Business by Onex Corporation and Baring Private Equity Asia. In May 13, 2019, Clarivate merged with Churchill Capital.
Clarivate owns and operates a collection of subscription-based services focused largely on analytics, including scientific and academic research, patent intelligence and compliance standards, pharmaceutical and biotech intelligence trademark, domain and brand protection. The services include Web of Science, Cortellis, Derwent, Derwent World Patents Index, CompuMark, MarkMonitor, Techstreet, Publons, EndNote, Kopernio, and ScholarOne.

Company history

Clarivate was formerly the Intellectual Property and Science division of Thomson Reuters.Before 2008 it was called as Thomson scientific. In 2016, Thomson Reuters struck a $3.55 billion deal in which they spun it off into an independent company, and sold it to private-equity firms Onex Corporation and Baring Private Equity Asia.
In May 13, 2019, Clarivate merged with Churchill Capital. Churchill's CEO, Jerre Stead became Clarivate's executive chairman.. On 29th July 2020,it started the process of Merging with CPA Global Ltd.

Products and services

Web of Science Group

Products providing data, analytics, insights, workflow tools, and professional services to researchers, universities, research institutions, governments, private and public research funding organizations, publishers, and research-intensive corporations, including:
Suite of life science intelligence solutions used to inform decision making across the drug and device development lifecycle, including:
Database products and services used for searching and analyzing patents; IP administration and prosecution support services to support the IP lifecycle, including:
Information services used by brand and trademark professionals to evaluate new potential trademarks and monitor existing trademarks for infringement, including:
Proprietary software and services for registering and managing the domain name portfolios, providing online brand protection, antipiracy and antifraud solutions, including:
Engineering industry standards, codes, and management tools for staying compliant in electronic, print and enterprise solutions, including:

Highly Cited Researchers

Clarivate publishes an annual Highly Cited Researchers list. The list recognizes "the world's most influential researchers of the past decade, demonstrated by the production of multiple highly-cited papers that rank in the top 1% by citations for field and year in Web of Science." Researchers are selected for their exceptional performance in one or more of 21 fields or across several fields. The 2019 list of Highly Cited Researchers was released on November 19, 2019.

Citation Laureates

Each year since 2002, Institute for Scientific Information analysts have drawn on Web of Science publication and citation data to identify influential researchers in the research areas recognized by Nobel Prizes: Physiology or Medicine, Physics, Chemistry and Economics. Out of some 47 million papers indexed in the Web of Science since 1970, only 4,900 have been cited 2,000 or more times. It is from the authors of this group of papers that Citation Laureates are identified and selected. The 2019 Citation Laureates were named on September 24, 2019.

Journal Citation Reports

Clarivate publishes the annual Journal Citation Reports, which identifies the world's most impactful academic journals included in the Science Citation Index Expanded and Social Sciences Citation Index, part of the Web of Science Core Collection. The 2019 Journal Citation Reports was released on June 20, 2019.

Drugs to Watch

The annual Drugs to Watch analysis, produced since 2013, identifies new drugs forecasted to achieve annual sales of $1 billion or more by 2023 using data and analytics from Cortellis life sciences solutions. The 2019 Drugs to Watch report] was released on March 20, 2019 and included drugs Upadacitinib, Zolgensma and Skyrizi

Acquisitions